Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Crippa

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2011
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™)A Canta, A Chiorazzi, V Carozzi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 26, 2019
The effect of delayed umbilical cord clamping on cord blood gas analysis in vaginal and caesarean-delivered term newborns without fetal distress: a prospective observational studyN Giovannini, B L Crippa, E Denaro, et al.
Tumori|May 7, 2002
Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicityG Beggiolin, L Crippa, E Menta, et al.
Nature Communications|November 20, 2023
Mott insulators with boundary zerosN Wagner, L Crippa, A Amaricci, et al.
Progress in Clinical and Biological Research|January 1, 1982
Workshop on DNA polymorphismsL Cavalli-Sforza, K Davies, K Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Diabetologia|October 1, 2009
Regression of diabetic complications by islet transplantation in the ratA Remuzzi, R Cornolti, R Bianchi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 14, 2015
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing miceC Meregalli, V A Carozzi, B Sala, et al.
Intensive Care Medicine|June 3, 1998
Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter studyF Baudo, T M Caimi, F de Cataldo, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|September 28, 2011
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)V Pengo, L Crippa, A Falanga, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2011
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™)A Canta, A Chiorazzi, V Carozzi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 26, 2019
The effect of delayed umbilical cord clamping on cord blood gas analysis in vaginal and caesarean-delivered term newborns without fetal distress: a prospective observational studyN Giovannini, B L Crippa, E Denaro, et al.
Tumori|May 7, 2002
Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicityG Beggiolin, L Crippa, E Menta, et al.
Nature Communications|November 20, 2023
Mott insulators with boundary zerosN Wagner, L Crippa, A Amaricci, et al.
Progress in Clinical and Biological Research|January 1, 1982
Workshop on DNA polymorphismsL Cavalli-Sforza, K Davies, K Smith, et al.
Journal of Thrombosis and Haemostasis : JTH|July 26, 2012
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent resultsV Pengo, L Crippa, A Falanga, et al.
Diabetologia|October 1, 2009
Regression of diabetic complications by islet transplantation in the ratA Remuzzi, R Cornolti, R Bianchi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 14, 2015
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing miceC Meregalli, V A Carozzi, B Sala, et al.
Intensive Care Medicine|June 3, 1998
Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter studyF Baudo, T M Caimi, F de Cataldo, et al.
Pageof 8